InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Moxham Christopher, Directeur Scientifique. Officer active across 1 companies, notably Fulcrum Therapeutics, Inc.. Cumulatively, 2 reports have been published. The latest transaction was disclosed on 10 August 2021 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€138,52520,714 shares@ €6.68750.031% mcap100.0% of flow
Common Stock
SEC:0000899243-21-032755·
€138,52520,714 shares@ €6.68750.031% mcap50.0% of flow
Common Stock
SEC:0000899243-21-032755:0·
2 of 2 declarations
About Moxham Christopher
Christopher Moxham is the Chief Scientific Officer at Fulcrum Therapeutics, Inc. He is responsible for scientific direction and innovation within the company. His role is essential in developing new treatments and therapeutic solutions.
